Presence of a complement-dependent "cytotoxic factor" in dog serum: relevance to experimental discordant xenotransplantation
Baker, J.; Martin, M.; Ye, Y.; Oleinick, S.; Zuhdi, N.; Cooper, D.K.
Transplantation Proceedings 24(2): 490-491
1992
ISSN/ISBN: 0041-1345 PMID: 1566399 Document Number: 394241
Document emailed within 1 workday
Related Documents
Li, Z-dong.; Shi, C-qing.; Zhang, Q-hua.; Xiong, Y-liang.; Zhou, X-ding.; Wang, W-yu.; Song, N. 2004: Mechanisms of purified cobra venom factor in preventing hyperacute rejection following discordant liver xenotransplantation in rats Zhonghua Yi Xue Za Zhi 84(23): 2007-2010Fearon, D.T.; Austen, K.F.; Ruddy, S. 1973: Serum proteins involved in decay and regeneration of cobra venom factor-dependent complement activation Journal of Immunology 111(6): 1730-1736
Richards, A.L.; Okuno, T.; Takagaki, Y.; Djeu, J.Y. 1988: Natural cytotoxic cell-specific cytotoxic factor produced by IL-3-dependent basophilic/mast cells. Relationship to TNF Journal of Immunology 141(9): 3061-3066
Sundsmo, J.S.; Curd, J.G.; Kolb, W.P.; Müller-Eberhard, H.J. 1978: Leukocyte complement: assembly of the membrane attack complex of complement by human peripheral blood leukocytes in the presence and absence of serum Journal of Immunology 120(3): 855-860
Tamerius, J.D.; Hellström, I. 1974: In vitro demonstration of complement-dependent cytotoxic antibodies to Moloney sarcoma cells Journal of Immunology 112(6): 1987-1996
Kozłowska, K.; Zurawska-Czupa, B.; Kostulak, A. 1985: Study on the complement-dependent cytotoxic effect of the sera of hamsters bearing transplanted melanoma Archivum Immunologiae et Therapiae Experimentalis 33(3): 435-442
Yamamoto, S.; Kawahara, K.; Takahashi, T.; Akamine, S.; Nagayasu, T.; Yamasaki, N.; Tomita, M. 1996: Pathologic examination of discordant lung xenotransplantation in the rat Transplantation Proceedings 28(3): 1418-1419
Huber, C.; Pfister, R.; Stingl, G. 1982: Complement-dependent lymphocytotoxic antibodies (CLA) in systemic lupus erythematosus preferentially inhibit the generation of alloreactive cytotoxic T cells in secondary CML Clinical and Experimental Immunology 50(3): 525-533
Rosengard, A.M.; Cary, N.; Horsley, J.; Belcher, C.; Langford, G.; Cozzi, E.; Wallwork, J.; White, D.J. 1995: Endothelial expression of human decay accelerating factor in transgenic pig tissue: a potential approach for human complement inactivation in discordant xenografts Transplantation Proceedings 27(1): 326-327
Aomatsu, Y.; Nakajima, Y.; Iwata, H.; Amemiya, H.; Kanehiro, H.; Hisanaga, M.; Yoshimura, A.; Kido, K.; Taki, J.; Horikawa, M. 1995: Significance of low doses of 15-deoxyspergualin in agarose-microencapsulated discordant islet xenotransplantation Transplantation Proceedings 27(1): 292-293
Chertov, O.I.; Krasnosel'skiĭ, A.L.; Lukanidin, E.M.; Sashchenko, L.N.; Gnuchev, N.V. 1989: Isolation of a cytotoxic factor from the blood serum of athymic rats Biulleten' Eksperimental'noi Biologii i Meditsiny 107(3): 329-331
Byers, P.H.; Ward, P.A.; Kellermeyer, R.W.; Naff, G.B. 1973: Complement as a mediator of inflammation in acute gouty arthritis. II. Biological activities generated from complement by the interaction of serum complement and sodium urate crystals Journal of Laboratory and Clinical Medicine 81(5): 761-769
Pearce, E.J.; Hall, B.F.; Sher, A. 1990: Host-specific evasion of the alternative complement pathway by schistosomes correlates with the presence of a phospholipase C-sensitive surface molecule resembling human decay accelerating factor Journal of Immunology 144(7): 2751-2756
Okada, M.; Henney, C.S. 1980: The differentiation of cytotoxic T cells in vitro. II. Amplifying factor(s) produced in primary mixed lymphocyte cultures against K/D stimuli require the presence of Lyt 2+ cells but not Lyt 1+ cells Journal of Immunology 125(1): 300-307
Pfueller, S.L.; Lüscher, E.F. 1974: Studies of the mechanisms of the human platelet release reaction induced by immunologic stimuli. I. Complement-dependent and complement-independent reactions Journal of Immunology 112(3): 1201-1210
Dorling, A. 2000: Graft-specific inhibition of complement activation after xenotransplantation; genetically modified pig organs versus systemic anticomplement strategies Transplantation 69(6): 1033-1034
Tanji, M.; Katz, B.H.; Spink, B.C.; Carpenter, D.O. 2000: Growth inhibition of MCF-7 cells by estrogen is dependent upon a serum factor Anticancer Research 20(4): 2779-2783
Grimm, H.; Schwemmle, K. 1998: Experimental xenotransplantation Zentralblatt für Chirurgie 123(7): 777-778
Brown, E.J.; Joiner, K.A.; Gaither, T.A.; Hammer, C.H.; Frank, M.M. 1983: The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system Journal of Immunology 131(1): 409-415
Mold, C.; Gewurz, H. 1980: Activation of human complement by liposomes: serum factor requirement for alternative pathway activation Journal of Immunology 125(2): 696-700